Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-ranging tranexamic acid for blood loss reduction in complex posterior lumbar surgery
ChiCTR-IPR-15006088Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tranexamic acid in lumbar spinal stenosis (LSS) and lumbar spondylolisthesis (4 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoint: Amount of hemorrhage. Started Mar 2015; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
lumbar spinal stenosis (LSS)lumbar spondylolisthesis
Beyond the preview
Go deeper on ChiCTR-IPR-15006088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006088.